According to Foghorn Therapeutics's latest financial reports the company's current earnings (TTM) are -โน7.97 B. In 2023 the company made an earning of -โน9.06 B an increase over its 2022 earnings that were of -โน9.58 B.The earnings displayed on this page is the company's Pretax Income.